Company / Profit Margin
AbCellera Biologics Inc. Profit Margin History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-194.9%
FY2025
5-year range
-564.8% / 51.0%
FY2021-FY2025
Trend
+65.5%
vs FY2024
Sector context
#109 of 145
Health Care
What the data says
AbCellera Biologics Inc.'s profit margin of -194.9% is lower than 75% of companies in the Health Care sector (FY2025). Profit Margin returned to growth in FY2025 after 2 years of decline, reaching -194.9%.
Based on SEC 10-K filings.
-194.9% in FY2025 with a 3-year CAGR of -245.9%.
Improved from -385.0% to -194.9% over the past 2 years.
Health Care sector context is included.
Profit Margin over time
Growth rates
- 3-Year Change
- -245.9pp
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
Bottom 25% in Health CareTop 75% of 145This company -194.9% Sector average -792.7%
▼
+75.4% above sector average
Key checks
Key Insights
- In FY2025, profit margin increased 65.5% year-over-year.
- Currently 597.8pp above the Health Care sector average.
- Peak profit margin was recorded in FY2022.
- Lowest profit margin in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score 0.93 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -194.9% | +65.5% |
| FY2024 | -564.8% | -46.7% |
| FY2023 | -385.0% | -854.9% |
| FY2022 | 51.0% | +367.9% |
| FY2021 | -19.0% | - |
| FY2020 | - | - |
| FY2019 | -19.0% | - |
As of FY2025 · SEC 10-K · Updated Jul 1, 2026